The Factors That May Predict Response to Rituximab Therapy in Recurrent Focal Segmental Glomerulosclerosis: A Systematic Review
Table 1
Demographic characteristics of renal transplant patients with recurrence FSGS that received rituximab. Values expressed as median (range) or proportion (%).